View Item 

Show simple item record

Permeation of Buprenorphine and Its 3-Alkyl-Ester Prodrugs Through Human Skin
dc.contributor.authorDua, Rajesh K.en_US
dc.contributor.authorWoodard, Ronald W.en_US
dc.contributor.authorFlynn, Gordon L.en_US
dc.contributor.authorStinchcomb, Audra L.en_US
dc.contributor.authorImoto, Hirofumien_US
dc.contributor.authorPaliwal, Anupamen_US
dc.date.accessioned2006-09-08T19:16:12Z
dc.date.available2006-09-08T19:16:12Z
dc.date.issued1996-10en_US
dc.identifier.citationStinchcomb, Audra L.; Paliwal, Anupam; Dua, Rajesh; Imoto, Hirofumi; Woodard, Ronald W.; Flynn, Gordon L.; (1996). "Permeation of Buprenorphine and Its 3-Alkyl-Ester Prodrugs Through Human Skin." Pharmaceutical Research 13(10): 1519-1523. <http://hdl.handle.net/2027.42/41449>en_US
dc.identifier.issn0724-8741en_US
dc.identifier.issn1573-904Xen_US
dc.identifier.urihttps://hdl.handle.net/2027.42/41449
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=8899844&dopt=citationen_US
dc.description.abstractPurpose . Homologous 3-alkyl-ester prodrugs (C 2 to C 4 ) of buprenorphine with decreased crystallinity have been synthesized and evaluated for transdermal delivery commensurate with opioid dependence treatment.en_US
dc.format.extent934926 bytes
dc.format.extent3115 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherKluwer Academic Publishers-Plenum Publishers; Plenum Publishing Corporation ; Springer Science+Business Mediaen_US
dc.subject.otherPharmacyen_US
dc.subject.otherPharmacology/Toxicologyen_US
dc.subject.otherBiomedical Engineeringen_US
dc.subject.otherCutaneous Metabolismen_US
dc.subject.otherPartition Coefficientsen_US
dc.subject.otherBiochemistry, Generalen_US
dc.subject.otherTransdermal Deliveryen_US
dc.subject.otherMedical Lawen_US
dc.subject.otherBuprenorphineen_US
dc.subject.otherBiomedicineen_US
dc.subject.otherProdrugsen_US
dc.titlePermeation of Buprenorphine and Its 3-Alkyl-Ester Prodrugs Through Human Skinen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelPharmacy and Pharmacologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumCollege of Pharmacy, The University of Michigan, Ann Arbor, Michigan, 48109en_US
dc.contributor.affiliationumCollege of Pharmacy, The University of Michigan, Ann Arbor, Michigan, 48109; School of Pharmacy, University of California, San Francisco, California, 94143-0446en_US
dc.contributor.affiliationumCollege of Pharmacy, The University of Michigan, Ann Arbor, Michigan, 48109; Sumitomo Pharmaceuticals Research Center, 3–45 Kurakakiuchi 1-Chome, Ibaraki-Shi, Osaka, 567, Japanen_US
dc.contributor.affiliationumCollege of Pharmacy, The University of Michigan, Ann Arbor, Michigan, 48109en_US
dc.contributor.affiliationumCollege of Pharmacy, The University of Michigan, Ann Arbor, Michigan, 48109en_US
dc.contributor.affiliationumCollege of Pharmacy, The University of Michigan, Ann Arbor, Michigan, 48109en_US
dc.contributor.affiliationumcampusAnn Arboren_US
dc.identifier.pmid8899844en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/41449/1/11095_2004_Article_306751.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1023/A:1016079513007en_US
dc.identifier.sourcePharmaceutical Researchen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
11095_2004_Article_306751.pdf
Size:
913.0KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.